Trial Profile
A Multicenter, Randomized, Parallel Groups, Placebo-controlled Study Comparing the Efficacy, Safety, and Tolerability of the Daily Coadministration of Ezetimibe 10 mg With Atorvastatin 10 mg in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease for Whom Diet and Exercise Have Failed.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Atorvastatin
- Indications Coronary artery disease; Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Schering-Plough
- 25 Jun 2014 New trial record